- 公司资讯
- finviz | 2022年07月21日 18:32Heron Therapeutics (NASDAQ:HRTX) shareholders have endured a 83% loss from investing in the stock three years ago
- finviz | 2022年07月19日 06:007 Biotech Stocks to Buy for Q3
- finviz | 2022年06月30日 20:41Heron Therapeutics to cut about one-third of its workforce as part of cost-cutting plan
- finviz | 2022年06月30日 20:30Heron Therapeutics Announces Restructuring and Cost Reduction Plan to Address Market Dynamics and Prepare for Long-Term Sustainability
- finviz | 2022年06月14日 20:30Heron Therapeutics Announces Publication Showing ZYNRELEF
- finviz | 2022年05月27日 04:05Heron Therapeutics to Present at the 2022 Jefferies Global Healthcare Conference
- finviz | 2022年05月17日 04:05Heron Therapeutics Presents ZYNRELEF
- finviz | 2022年05月10日 06:45Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates
- finviz | 2022年05月10日 04:05Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Recent Corporate Updates
- finviz | 2022年05月04日 04:05Heron Therapeutics to Report First Quarter 2022 Financial Results on Monday, May 9, 2022
- finviz | 2022年04月06日 04:05Heron Therapeutics to Present at the 21st Annual Virtual Needham Healthcare Conference
- finviz | 2022年03月29日 03:14Short Sellers Are Targeting These 10 Stocks
- finviz | 2022年03月25日 20:30Heron Therapeutics Secures Pass-through Payment Status for ZYNRELEF
- finviz | 2022年03月17日 20:30Heron Therapeutics Announces Approval of ZYNRELEF
- finviz | 2022年03月05日 04:00Up 1,000% in 5 Years? These Healthcare Stocks Could Pull It Off.
- finviz | 2022年03月03日 04:05Heron Therapeutics to Present at 42nd Annual Cowen Healthcare Conference